Ofev (nintedanib)

pCPA File Number: 20886

Negotiation Status:

Concluded with an LOI

Indication(s):

Idiopathic pulmonary fibrosis (IPF)

Sponsor/Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

CADTH Project Number:

SR0426-000

pCPA Engagement Letter Issued:

2015-10-27

Negotiation Process Concluded:

2016-08-29